Dr Lal PathLabs decent bet: Mehraboon Irani

Mehraboon Irani of Nirmal Bang Securities told CNBC-TV18, "I wouldn’t know as to what technical factors are paying in Dr Lal PathLabs today because on a day when the markets are up or the stock which has attracted so much of fancy on listing before their IPO closed everybody is talking about it. At Rs 700 this stock is definitely not a bad bet, it is a fairly decent bet." "I think the IPO pricing was brilliant. There was money left on the table for investors, people flocked to it. At Rs 700 if everything is as good as what it was at the time of IPO something that has not come out which I really don’t know, at Rs 700 I would say the stock definitely merits fresh attention," he said.